Management of Hallucinations and Depression After Discontinuation of Memory Medication

Immediate Action Required

The American Geriatrics Society recommends that patients with hallucinations and depression after discontinuation of memory medication require immediate referral to a mental health professional for comprehensive psychiatric evaluation, as this represents a potentially serious neuropsychiatric emergency 1, 2

The American Geriatrics Society suggests that medication withdrawal, such as abrupt discontinuation of cholinesterase inhibitors, can precipitate neuropsychiatric symptoms including hallucinations and worsening cognition 1
The American Academy of Ophthalmology notes that Charles Bonnet Syndrome, a benign condition, may be represented by recurrent visual hallucinations with insight that they are not real, particularly in patients with vision impairment 3
The American Geriatrics Society recommends evaluating vital signs and physical examination looking for signs of infection, dehydration, pain, or acute medical illness 1

The American Geriatrics Society recommends referring patients immediately if they are threatening harm to self or others, have severe agitation or inability to care for self, lack of insight that hallucinations are not real, or have suicidal ideation 1, 3

The American Geriatrics Society advises against initiating antipsychotic medications for hypoactive delirium or non-agitated hallucinations in older adults with cognitive impairment due to substantial risks of increased morbidity and mortality 2
The American Geriatrics Society recommends avoiding benzodiazepines for hallucinations or depression, as they increase delirium risk, prolong delirium duration, and significantly increase fall risk in older adults 2, 5, 6

The American Geriatrics Society suggests implementing environmental modifications, such as optimizing lighting and reducing noise, to help manage hallucinations 1, 2
The American Academy of Ophthalmology recommends addressing sensory deficits, such as checking vision and hearing, as visual impairment increases risk of Charles Bonnet Syndrome 3

The American Geriatrics Society advises against dismissing hallucinations as "pseudo-hallucinations" or assuming they are transient without proper assessment, and against combining multiple sedating medications except in crisis situations 5, 6
The American Geriatrics Society recommends not attributing everything to depression, as hallucinations in cognitive impairment require thorough evaluation for delirium and neurodegenerative causes 1, 2